Search

everythinglearnresearchcommunity

for

Search:↓

Older, overweight women with children and a family history of hair loss are more likely to experience female pattern hair loss.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Central lipohypertrophy in HIV-infected women may lead to shorter eyelashes.

Videodermoscopy better identifies female hair loss than clinical diagnosis.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Nourkrin® Woman with Marilex® improves hair growth, appearance, and confidence in women with hair loss.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Aging alone rarely causes significant hair loss; hormones are a bigger factor.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Wiesbaden 30C effectively reduces hair fall and improves hair growth in young adults with Telogen Effluvium.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Hair loss severity relates to increased miniaturization in female pattern hair loss.